In Brief: SmithKline Beecham
This article was originally published in The Tan Sheet
SmithKline Beecham: Signs agreement with Penederm to market several undisclosed products in Eastern and Western Europe and the Middle East using Penederm's TopiCare Delivery Compounds. The companies are projecting that marketing will begin by the start of the fourth quarter. Penederm describes its TopiCare product as "patented polymers that improve the effects or delivery of the active ingredients" in OTC, prescription and cosmetic products...
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC